Antimicrobial, Antioxidant, Anti-Inflammatory, and Cytotoxic Activities of Propolis from the Stingless Bee Tetragonisca fiebrigi (Jataí) by Campos, Jaqueline Ferreira et al.
Research Article
Antimicrobial, Antioxidant, Anti-Inflammatory,
and Cytotoxic Activities of Propolis from the Stingless Bee
Tetragonisca fiebrigi (Jataí)
Jaqueline Ferreira Campos,1 Uilson Pereira dos Santos,1 Paola dos Santos da Rocha,1
Marcio José Damião,1 José Benedito Perrella Balestieri,1 Claudia Andrea Lima Cardoso,2
Edgar Julian Paredes-Gamero,3 Leticia Miranda Estevinho,4 Kely de Picoli Souza,1 and
Edson Lucas dos Santos1
1School of Environmental and Biological Science, Federal University of Grande Dourados, Rodovia Dourados-Itahum,
Km 12, 79804-970 Dourados, MS, Brazil
2Course of Chemistry, State University of Mato Grosso do Sul, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil
3Department of Biochemistry, Federal University of Sa˜o Paulo, Rua Pedro de Toledo 669, 04039-032 Sa˜o Paulo, SP, Brazil
4CIMO/ESA, Department of Biology and Biotechnology, Agricultural College of Braganc¸a, Polytechnic Institute of Braganc¸a,
Campus Santa Apolo´nia, 5301-855 Braganc¸a, Portugal
Correspondence should be addressed to Edson Lucas dos Santos; edson.lucas@pq.cnpq.br
Received 15 April 2015; Revised 3 June 2015; Accepted 3 June 2015
Academic Editor: Vincenzo De Feo
Copyright © 2015 Jaqueline Ferreira Campos et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Propolis from stingless bees Tetragonisca fiebrigi found in Brazil is used in folk medicine by their nutritional and therapeutic
properties. However, there are no scientific records evidencing such properties. The present study was designed to investigate
the chemical composition and the biological properties of propolis from T. fiebrigi. For this, the chemical composition of the
ethanol extract of propolis (EEP) was determined by GC-MS and presented phenolic compounds, alcohol, and terpenes as its major
class compounds. The antimicrobial activity was accessed in gram-positive and gram-negative bacteria and in fungi, isolated from
different biological fluids and reference strains. The EEP was active against all microorganisms and showed antioxidant activity
by scavenging free radicals, inhibiting hemolysis and lipid peroxidation in human erythrocytes incubated with an oxidizing agent.
The anti-inflammatory potential of the EEP was confirmed by inhibition of the hyaluronidase enzyme. The cytotoxic activity was
concentration-dependent against K562 cells, with a predominance of death by necrosis. Taken together, these results show that
propolis from T. fiebrigi has important therapeutic activities, which suggest its potential application in the pharmaceutical industry,
as well as in health foods, beverages, and nutritional supplements.
1. Introduction
More than 200 species of stingless bees have been described
in Brazil [1]. Among these species, Tetragonisca fiebrigi,
popularly known in Brazil as Jataı´ or abelha-ouro (golden
bee), covers a large part of the Brazilian territory, including
themidwest, south, and southeast regions, aswell as countries
such as Argentina, Bolivia, and Paraguay [2, 3]. Recently, the
taxonomic classification of this species has been revised. The
species was previously described as Tetragonisca angustula
fiebrigi subspecies alongwithT. a. angustula; however,molec-
ularmarkers studies showed them to be distinct species [4, 5].
Among the species of stingless bees, T. fiebrigi is known
as a good producer of honey and propolis, which are highly
prized in folk medicine for their nutritional and therapeutic
properties. Despite the popular use of these products, only
the antibacterial and antioxidant properties of the honey
produced by this species have been described in the literature
[6, 7], and there are no scientific records of the therapeutic
properties attributed to the propolis produced by these bees.
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Propolis is a resinous substance produced by bees
through the mixture of jaw secretions and the exudate
collected from plant materials [8, 9]. This resin is used
in the construction, maintenance, and asepsis of the nest
[10]. There are records that ancient civilizations, such as the
Incas, Greeks, Egyptians, and Romans, used propolis for its
therapeutic properties, being described as antiseptic, healing,
and antipyretic [11]. Additionally, this natural product has
also been used in the preparation of drinks and foods for
human nutrition, aiming at the improvement in health and
disease prevention [12].
Indeed, recent studies expanded the knowledge on the
therapeutic applications of propolis from different species
of stingless bees, describing their antimicrobial [13, 14],
antioxidant [15, 16], and antitumor [12, 17] properties.
These medicinal properties are directly related to the
chemical composition. Studies of propolis from stingless
bees describe the presence of phenolic acids, aromatic acids,
terpenes, and carbohydrates [1, 16, 18]. The bee species and
the botanical source from which the bees collect the resin are
among the factors responsible for the physical, chemical, and
biological characteristics of the propolis [12, 15].
Therefore, this study describes for the first time the
chemical composition and antimicrobial, antioxidant, anti-
inflammatory, and cytotoxic properties of propolis produced
by the stingless bee T. fiebrigi.
2. Materials and Methods
2.1. Preparation of the Ethanol Extract of Propolis (EEP).
Propolis samples from T. fiebrigi bees (see Supplementary
Material available online at http://dx.doi.org/10.1155/2015/
296186) were collected from the state of Mato Grosso do
Sul, in the midwest region of Brazil. Three colonies were
identified, and six samples of propolis were collected with
approximately 2.14 g each. The ethanol extract of propolis
(EEP) was prepared with 4.5mL of 80% ethanol per 1 g of
propolis, kept in a water bath at 70∘C in a sealed container
until total dissolution, and subsequently filtered to obtain the
EEP [19].
2.2. Chemical Analysis. One milligram of dry extract was
reactedwith 50𝜇Lpyridine + 100𝜇L bis(trimethylsilyl) triflu-
oroacetamide (BSTFA) including 1% trimethylchlorosilane
(TMCS) in a sealed glass tube for 30min at 100∘C to
prepare samples for gas chromatography [20].The procedure
was performed in triplicate. Samples were injected and
analyzed by gas chromatography-mass spectrometry (GC-
MS). The procedure was performed in triplicate. The GC-
MS analysis was performed on a gas chromatograph (GC-
17A, Shimadzu, Kyoto, Japan) equipped with a mass spec-
trometer detector (QP 5050a), using DB-5 (J&W, 5% phenyl-
dimethylpolysiloxane), fused-silica capillary column (30m in
length × 0.25mm i.d., and 0.25 𝜇m film thickness), under
the following conditions: carrier gas of helium (99.999% and
flow rate 1.0mLmin−1), 1 𝜇L injection volume, split ratio
(1 : 10), initial oven temperature set at 85∘C, and heating
from 85∘ to 315∘C at 4∘Cmin−1. The injector temperature
was 280∘C, and the quadrupole detector temperature was
315∘C. The MS scan parameters included an electron-impact
ionization voltage of 70 eV, mass range of 45–600 m/z, and
scan interval of 0.5 s. Temperature-programmed retention
indices [21] were calculated using mixtures of linear alkane
(C
8
–C
30
) as external references. The identifications were
completed by comparing the mass spectra obtained in the
QP5050 libraries. In some cases, when identified spectra were
not found, only the structural type of the corresponding
component was proposed on the basis of its mass-spectral
fragmentation. When possible, reference compounds were
cochromatographed to confirm GC-retention times.
2.3. Antimicrobial Activity. In the present study microor-
ganisms isolated from biological fluids were used, collected
in the Hospital Centre, and identified in the Microbiology
Laboratory of Escola Superior Agraria de Braganca (ESA),
but also reference strains were obtained from the authorised
distributor of ATCC (LGC Standards S.L.U., Barcelona). The
microorganisms were Staphylococcus aureus ATCC 43300,
S. aureus ESA 654, Staphylococcus epidermidis ATCC 12228,
S. epidermidis ESA 675, Enterococcus faecalis ATCC 43300,
E. faecalis ESA 553, Klebsiella pneumonia ATCC 4352, K.
pneumoniae ESA 154, Pseudomonas aeruginosa ATCC 15442,
P. aeruginosa ESA 22, Proteus mirabilis ATCC 43300, P.
mirabilis ESA 37, Candida glabrata ATCC 90030, C. glabrata
ESA 123, Candida albicans ATCC 90028, and C. albicans
ESA 345. The isolates were stored in Muller-Hinton medium
plus 20% glycerol at −70∘C, before experimental use. The
inoculum for the assays was prepared by diluting cell mass
in 0.85% NaCl solution, adjusted to 0.5 in MacFarland scale,
confirmed by spectrophotometric reading at 580 nm for
bacteria and 640 nm for yeasts. Cell suspensions were finally
diluted to 104 CFU/mL in order to use them in the activity
assays. Antimicrobial tests were carried out as previously
described by Silva et al. [22], using Nutrient Broth (NB) or
Yeasts Peptone Dextrose (YPD) on microplate (96 wells).
Propolis extracts were diluted in dimethyl sulfoxide (DMSO)
and transferred into the first well and serial dilutions were
performed. The inoculum was added to all wells and the
plates were incubated at 37∘C for 24 h (bacteria) and 25∘C
for 48 h (yeast). Amphotericin B and gentamicin were used
as controls. In each experiment a positive control (inoculated
medium) and a negative control (medium) and DMSO
control (DMSO with inoculated medium) were introduced.
Antimicrobial activity was detected by adding 20 𝜇L of 0.5%
TTC solution (2,3,5-triphenyl-2H-tetrazolium chloride).The
minimum inhibitory concentration (MIC) was defined as the
lowest concentration of propolis extract that inhibited visible
growth, as indicated by the TCC staining (dead cells are not
stained by TTC).
In order to determine the Minimal Bactericidal Con-
centration (MBC) and Minimal Fungicidal Concentration
(MFC), a portion of liquid (20𝜇L) from each well in which
colour changes were not verified was plated on NB or YPD
and incubated at 37∘C for 24 h (bacteria) and for 48 h (yeast).
The lowest concentration that yielded no growth after this
subculturing was taken as the MBC or MFC. All tests were
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performed in triplicate (𝑛 = 3) and results are expressed as
mg/mL.
2.4. Antioxidant Activity
2.4.1. ABTS Radical Scavenging Assay. Free radical scav-
enging capacity for EEP was studied as described by Re
et al. [23], through the evaluation of the free radical
scavenging effect on 2,2󸀠-azinobis-(3-ethylbenzothiazoline-
6-sulfonic acid) (ABTS) radical.The stock solutions included
7mM ABTS solution and 140mM potassium persulphate
solution. The ABTS∙+ radical was then prepared by mixing
the two stock solutions (5mL of ABTS solution and 88𝜇L
potassium persulphate solution) and left for 12–16 h at room
temperature in the dark. The solution was then diluted by
mixing 1mL ABTS∙+ radical with 50mL ethanol absolute to
obtain an absorbance of 0.70 nm ± 0.05 units at 734 nm using
a spectrophotometer. Then, 20 𝜇L of EEP (0.1–500𝜇g/mL)
was mixed with 1980𝜇L of the ABTS∙+ radical and the
absorbance was taken at 734 nm after 6min using a spec-
trophotometer. Ascorbic acid and butylated hydroxytoluene
(BHT) were used as positive controls. Two independent
experiments were performed in triplicate. The percentage of
inhibition of the ABTS radical was calculated according to
the following equation, where Abscontrol is the absorbance of
ABTS∙+ radical without the tested sample:
% inhibition of ABTS = (
(Abscontrol − Abssample)
Abscontrol
)
×100.
(1)
2.4.2. Antioxidant Assay Using a Human Erythrocyte Model
(1) Preparation of Erythrocyte Suspensions. Following
approval by the Research Ethics Committee (Comiteˆ de
E´tica em Pesquisa; CEP) of the University Center of Grande
Dourados (Centro Universita´rio da Grande Dourados;
UNIGRAN), Brazil (CEP process number 123/12), 10mL
of peripheral blood was collected from healthy donors
into sodium citrate-containing tubes and was subsequently
centrifuged at 1500 rpm for 10min. After centrifugation,
the blood plasma and leukocyte layers were discarded, and
the erythrocytes were washed 3 times with saline solution
and centrifuged. Finally, 10% erythrocyte suspension was
prepared in saline, to obtain a final 2.5% after the treatments.
(2) Hemolytic Activity and Oxidative Hemolysis Inhibition.
The protective effect of the propolis extract was evaluated
according to the method described by Campos et al. [16],
with minor modifications. The assays were conducted with
erythrocyte suspensions.The erythrocytes were preincubated
at 37∘C for 30min in the presence of different concentrations
of EEP or ascorbic acid (25–125 𝜇g/mL). Then, 50mM 2,2󸀠-
azobis-(2-amidinopropane) dihydrochloride (AAPH) solu-
tion was added. A sample of 0.2% ethanol was used as a
negative control. Total hemolysis was induced by incubating
erythrocytes with distilled water. Basal hemolysis caused
by EEP was assessed by incubating erythrocytes with the
extract without the presence of AAPH, and the control was
assessed in erythrocytes incubated only with 0.9%NaCl.This
mixture was incubated at 37∘C for 240min, with periodical
stirring. Hemolysis was determined after every 60min of
sample incubation for a total of 240min; specifically, aliquots
were removed, diluted in saline, and centrifuged at 1500 rpm
for 10min, after which the absorbance of the supernatant
was read spectrophotometrically at 540 nm. The percentage
hemolysis was measured with the formula 𝐴/𝐵 × 100, where
(𝐴) is the sample absorbance and (𝐵) is the total hemolysis.
Two independent experiments were performed in duplicate.
(3) Inhibitory Efficiency against Lipid Peroxidation. The pro-
tective effect of EEP against lipid peroxidation was evaluated
according to the method described by Campos et al. [16],
with minor modifications. Erythrocytes were preincubated
at 37∘C for 30min with different concentrations of EEP or
ascorbic acid (25–125 𝜇g/mL). A sample of 0.2% ethanol was
used as a negative control. Next, 50mMAAPH was added to
the erythrocyte solution, which was then incubated at 37∘C
with periodical stirring. Dosage of malondialdehyde (MDA),
a byproduct derived from lipid peroxidation, was determined
after every 60min of sample incubation for a total of 240min.
The samples were centrifuged at 1500 rpm for 10min, and
500𝜇L aliquots of the supernatant were transferred to tubes
with 1mL of 10 nmol thiobarbituric acid (TBA). As a standard
control, 500 𝜇L of 20mM MDA solution was added to 1mL
of TBA. The samples were incubated at 96∘C for 45min. The
samples were then cooled, 4mL of n-butyl alcohol was added,
and the samples were centrifuged at 3000 rpm for 5min.
The sample supernatants were removed, and the absorbance
was read at 532 nm. Two independent experiments were
performed in duplicate. MDA levels in the samples were
expressed in nmol/mL, obtained with the following formula:
MDA = Absorbancesample
×(
20 × 220.32
AbsorbanceMDAstandard
) .
(2)
2.5. Anti-Inflammatory Activity: Hyaluronidase Assay. The
inhibition of hyaluronidase activity was determined using the
method described by Silva et al. [22]. The reaction mixture
is constituted by 50 𝜇L of propolis’ extract and 50 𝜇L (350
units) of hyaluronidase enzyme (type IV-S: bovine testes)
was incubated at 37∘C for 20min. Then, calcium chloride
was added (1.2 𝜇L, 2.5 × 10−3M/L) to activate the enzyme
and the mixture was incubated at 37∘C for 20min. To
start the reaction 0.5mL of hyaluronic acid sodium salt
(0.1M/L) was added. The mixture was incubated at 37∘C
for 40min. After this, 0.1mL of potassium tetraborate 0.8M
was added and it was incubated in water bath at ebullition
for 3min. The mixture was placed at 10∘C and 3mL of p-
dimethylaminobenzaldehyde was added. Afterwards, it was
incubated at 37∘C for 20min. Finally, the absorbance was
measured at 585 nm using water as control. All the tests were
performed in triplicate.
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Figure 1: GC-MS profile of EEP from T. fiebrigi.
2.6. Cytotoxic Activity and Cell Death Profile. The K562
erythroleukemia cell line was grown in suspension in RPMI
1640 media (Cultilab, Campinas, Sao Paulo, Brazil) sup-
plemented with 10% fetal bovine serum (FBS; Cultilab),
100U/mL of penicillin, and 100 𝜇g/mL of streptomycin in a
humidified atmosphere at 37∘C in 5% CO
2
. The cytotoxic
activity and cell death profile were evaluated according to
the method described by Paredes-Gamero et al. [24], with
minor modifications. Cells were seeded into 96-well plates
(105 cells/mL) and cultured in medium with 10% FBS in
the absence or presence of EEP (31–500𝜇g/mL) for 24 h.
After this period, the K562 cells were washed with PBS
and resuspended in annexin-labeling buffer (0.01M HEPES,
pH 7.4, 0.14M NaCl, and 2.5mM CaCl
2
). The suspensions
were stained with annexin-FITC and propidium iodide (PI)
(Becton Dickinson, Franklin Lakes, NJ, USA), according to
the manufacturer’s instructions. The cells were incubated
at room temperature for 15min. Ten thousand events were
collected per sample, and the analyses were performed on
a FACSCalibur flow cytometer (Becton Dickinson) with
CellQuest software (Becton Dickinson). All the tests were
performed in duplicate.
2.7. Statistical Analyses. The data are shown as the mean ±
standard error of the mean (SEM) and were analyzed for
statistical significant differences between the groups, using
Student’s 𝑡-test, comparing the treatment with the control,
using the Prism 5 GraphPad Software. The results were
considered significant when 𝑃 < 0.05.
3. Results
3.1. Chemical Composition. The identification of the propo-
lis components was based on mass spectra interpretation,
retention index, and basis data. The major compounds were
benzoic and kaurenoic acids in relative area (Figure 1). The
EEP components were identified and listed in Table 1.
3.2. Antimicrobial Activity. The EEP showed antimicrobial
activity against all microorganisms evaluated (Table 2). The
propolis from T. fiebrigi presented greater activity against the
gram-positive bacteria than against gram-negative bacteria.
The inhibition observed followed the sequence: S. aureus >
S. epidermidis > E. faecalis > P. mirabilis > K. pneumonia >
P. aeruginosa. Apart from this inhibitory activity, the EEP
had bactericidal effects against all the organisms under study,
ranging from 1.50±0.14mg/mL, for the reference strain of S.
aureus, to 15.50 ± 0.29mg/mL, for the isolated P. aeruginosa.
Regarding the fungicidal activity, it was observed both in the
reference stains and in those isolated from biological fluids.
3.3. ABTS Radical Scavenging Assay. Considering the pres-
ence of potentially antioxidant substances, an in vitro evalu-
ation of the ABTS∙+ radical scavenging activity of EEP was
performed at different concentrations. The 50% inhibitory
concentration (IC
50
) and the maximal ABTS∙+ radical scav-
enging activity of EEP and the controls used are shown in
Table 3. The IC
50
of EEP was approximately five times higher
than that of synthetic antioxidant BHT.
3.4. Oxidative Hemolysis Inhibition Assay. The EEP was also
evaluated for its hemolytic activity and ability to protect
erythrocytes against AAPH-induced hemolysis. When ery-
throcytes were incubated only with ascorbic acid or EEP,
no hemolysis was observed at the times and concentrations
tested (Figure 2(a)), indicating that, at the concentrations
evaluated, the extract is not toxic to this cellular model.
Next, the ability to protect against AAPH-induced cell lysis of
human erythrocytes was evaluated. The EEP showed antihe-
molytic activity at all experimental period in a concentration
and time-dependent manner (data not shown). After a 240-
min incubation of erythrocytes with EEP, a reduction of 46 ±
3.6% of hemolysis was observed in the highest concentration
evaluated (Figure 2(b)).
3.5. Efficiency of EEP on the Inhibition of AAPH-Induced
Lipid Peroxidation. The ability of the EEP to protect against
AAPH-induced lipid peroxidation of human erythrocytes
was evaluated through the dosage of MDA.The EEP showed
reduced MDA levels at all experimental period in a con-
centration and time-dependent manner (data not shown).
After a 240-min incubation of erythrocytes with EEP, a
reduction of 39.5±2.4% ofMDAwas observed in the highest
concentration evaluated (Figure 2(c)).
3.6. Anti-Inflammatory Activity. It was observed that the
EEP inhibited the hyaluronidase enzyme in a concentration-
dependent manner. The highest concentration of extract
evaluated (75mg/mL) was able to inhibit 43.06 ± 3.06% of
enzymatic activity (Figure 3).
3.7. Cytotoxic Activity and Cell Death Profile. The K562
erythroleukemia cells treated with different concentrations
of EEP were stained with annexin V-FITC/PI to verify
the cell death profile. The EEP showed concentration-
dependent cytotoxicity. At the highest concentration eval-
uated (500 𝜇g/mL), there was a reduction of 67 ± 2.5% of
the viable cells (Figures 4(a) and 4(b)). The most effective
cytotoxic concentrations of propolis, 250 and 500𝜇g/mL,
promoted cell death by necrosis (23 ± 1.0 and 56 ± 1.4%)
and secondary necrosis (10±1.8 and 13±0.8%), respectively,
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Table 1: Compounds identified in EEP from T. fiebrigi by GC-MS.
Peak Retention time (min) Molecular mass Compound % TIC∗
1 13.10 122 Benzoic acid 9.2
2 15.31 286 Cinnamyl caffeate 1.5
3 21.04 270 Benzyl caffeate 1.5
4 23.76 148 Cinnamic acid 3.6
5 23.88 150 Hydrocinnamic acid 1.3
6 24.51 178 Hydrocinnamic acid ethyl ester 0.6
7 40.86 164 p-Coumaric acid 0.4
8 47.03 232 3-Phenyl-p-coumaric acid 2.8
9 50.67 180 Fructose 0.6
10 56.12 180 Glucose 1.5
11 59.94 302 Kaurenoic acid 11.8
12 63.25 152 4-Methoxybenzoic acid 3.0
13 68.59 286 Retinol 8.1
14 76.89 386 Cholesterol 12.4
15 79.39 430 Tocopherol 7.4
∗TIC: total ion current. The ion current generated depends on the characteristics of the compounds.
Table 2: Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration
(MFC) for same microorganisms gram-positive bacteria, gram-negative bacteria, and the fungi.
EEP (mg/mL) Gentamicin (𝜇g/mL)
MIC MBC MBC
Gram-positive bacteria
Staphylococcus aureus ATCC 43300 0.55 ± 0.05 1.50 ± 0.14 1.67 ± 0.17
Staphylococcus aureus ESA 654 0.65 ± 0.03 2.00 ± 0.14 1.33 ± 0.08
Staphylococcus epidermidis ATCC 12228 0.77 ± 0.02 1.75 ± 0.14 2.17 ± 0.17
Staphylococcus epidermidis ESA 675 0.88 ± 0.04 1.92 ± 0.36 2.00 ± 0.14
Enterococcus faecalis ATCC 43300 0.88 ± 0.07 3.8 ± 0.17 3.31 ± 0.20
Enterococcus faecalis ESA 553 1.02 ± 0.12 5.00 ± 0.14 3.33 ± 0.17
Gram-negative bacteria
Klebsiella pneumoniae ATCC 4352 3.33 ± 0.22 11.58 ± 0.22 5.00 ± 0.29
Klebsiella pneumoniae ESA 154 3.75 ± 0.14 13.08 ± 0.22 5.08 ± 0.17
Pseudomonas aeruginosa ATCC 15442 5.83 ± 0.46 14.42 ± 0.22 4.91 ± 0.08
Pseudomonas aeruginosa ESA 22 7.91 ± 0.22 15.50 ± 0.29 5.00 ± 0.29
Proteus mirabilis ATCC 43300 2.25 ± 0.14 10.75 ± 0.38 8.67 ± 0.17
Proteus mirabilis ESA 37 3.08 ± 0.22 12.02 ± 0.30 8.92 ± 0.22
EEP (mg/mL) Amphotericin B (𝜇g/mL)
MIC MFC MFC
Fungi
Candida glabrata ATCC 90030 7.00 ± 0.29 9.00 ± 0.29 0.86 ± 0.08
Candida glabrata ESA 123 7.91 ± 0.27 11.83 ± 0.40 1.37 ± 0.19
Candida albicans ATCC 90028 7.90 ± 0.31 8.00 ± 0.29 0.75 ± 0.03
Candida albicans ESA 345 9.25 ± 0.38 12.91 ± 0.22 0.75 ± 0.03
Values are shown as means ± SEM (𝑛 = 3).
indicating a concentration-dependent activity (Figures 4(a)
and 4(b)).
4. Discussion
Propolis is a natural product that has a complex chem-
ical composition. Substances in propolis composition are
potentially responsible for its biological activity and may
act synergistically and in an isolated manner. In this study,
phenolic compounds, aromatic acids, alcohols, terpenes, and
sugars were observed in the EEP from T. fiebrigi. These
compounds have been identified in other studies of propolis
of stingless bees found in Brazil [18, 25].
Even though the antimicrobial drugs have long been
used either for prophylactic or therapeutic purposes,
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Figure 2: Human erythrocytes incubated at 240min with ascorbic acid and EEP of T. fiebrigi (25–125𝜇g/mL). (a) Hemolytic activity of
treatmentswithout the presence ofAAPHand erythrocytes incubated onlywith 0.9%NaCl as control. (b)Hemolysis assessment after addition
of AAPH in erythrocytes incubated with ascorbic acid and EEP. (c) Concentration of malondialdehyde (MDA) in nmol/mL after adding the
oxidizing agent in erythrocytes incubated with different concentrations of treatments. * represents statistically significant results (𝑃 < 0.05)
when the treated group was compared to the AAPH group (erythrocytes incubated only with oxidizing agent).
Table 3: IC50 and maximum activity of ABTS radical scavenging of
standard antioxidants and of EEP.
Sample IC50 (𝜇g/mL)
Maximum inhibition
% 𝜇g/mL
Ascorbic acid 1.3 ± 0.2 99.5 ± 0.2 5
BHT 22.8 ± 4.2 85.2 ± 5.5 50
EEP 119.6 ± 20.5 86.5 ± 2.8 500
Values are means ± SEM (𝑛 = 2).
the emergence of drug-resistant microorganisms appears as
a serious global concern. In this context, it is important to
find other substances effective against pathogens resistant
to the conventional therapies. Natural products, such as
propolis, appear as a viable alternative, either by taking
advantage of the synergistic effects of all the compounds
present or by investing in specific isolated compounds.
Indeed, different studies have shown a positive cor-
relation between phenolic compounds and terpenes with
antimicrobial action [26, 27].
Phenolic compounds cinnamic acid, p-coumaric acid,
and the diterpene kaurenoic acid identified in EEP from
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Figure 3: Anti-inflammatory activity for inhibition of the activity of
hyaluronidase by the EEP in different concentrations.
T. fiebrigi already were described as being responsible for
the antibacterial activity of propolis from Melipona quadri-
fasciata anthidioides [26], Tetragonisca angustula, and Apis
mellifera [18], other species of bees found in Brazil.
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Figure 4: Cytotoxic action of EEP from T. fiebrigi against the K562 erythroleukemia cell line. (a) Representative diagrams obtained by flow
cytometry of cells stained with annexin V-FITC/PI: the lower left quadrant (PI−/An−) represents the viable cells; the lower right quadrant
(PI−/An+) represents the apoptotic cells; the upper left quadrant (PI+/An−) represents cells in necrosis; and the upper right quadrant (PI+/An+)
represents cells in secondary necrosis. (b) Frequency of cell death, obtained from the corresponding diagrams of tested concentrations. *𝑃 <
0.05 treated group versus control viable cells. #𝑃 < 0.05 treated group versus control necrosis.
The phenolic compounds are described as important
antibacterial agents that inhibit bacteria by promoting dam-
age to the cell membrane and by inhibiting the synthe-
sis of nucleic acids and the energy metabolism of these
microorganisms. In addition, these compounds interferewith
virulence factors of various bacteria, including enzymes,
toxins, and other signaling molecules [28].
The EEP from T. fiebrigi showed antimicrobial activity
against the gram-positive bacteria, gram-negative bacteria,
and fungi, which is important for health maintenance, since
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that thesemicroorganisms are responsible for commonnoso-
comial infections in urinary tract, respiratory pneumonia,
surgical site wound, gastrointestinal, and skin infections
[22]. Propolis acts by inhibiting the growth and prolifer-
ation of bacteria [29]; however, gram-positive bacteria are
more sensitive to the action of propolis than gram-negative
bacteria, which may be due to structural differences of the
cell wall [14, 25]. Mirzoeva et al. [30] suggested that the
antimicrobial activity of propolis is species-dependent and
that its constituents are able to promote an increase in
membrane permeability and inhibit bacterial motility.
Among the antimicrobial activities of propolis, the EEP
showed fungicidal properties against C. glabrata and C.
albicans. Kujumgiev et al. [31] correlated the antifungal effect
of Brazilian propolis with the presence of diterpene acids,
triterpenes, aromatic acids, and phenolic compounds, which
were also identified in propolis from T. fiebrigi.
Gallucci et al. [32] showed that many phenolic com-
pounds inhibit fungal growth by interacting with the plasma
or mitochondrial membrane of the fungus. de Castro et al.
[33] reported that the mechanisms by which propolis pro-
motes the death of fungi include vacuolar acidification
and changes in the mitochondrial electron-transport chain,
resulting in death by apoptosis; in turn, prolonged exposure
results in secondary necrosis.
Recently, de Castro et al. [34] reported that propolis
inhibits the morphological transition from yeast to hyphae,
thus promoting the control of cell growth and differentiation,
and induces cell death through the metacaspase pathway.
Ramsdale [35] noted that many antifungal compounds pro-
mote cell death mediated by the apoptotic pathway and can
be metacaspase dependent or independent. In addition, anti-
fungal compounds stimulate the production of reactive oxy-
gen species or interfere with calcium/calmodulin/calcineurin
signaling. The discovery of new antifungal agents, especially
those that promote cell death by different pathways, from
natural sources is of great importance.
In addition to the antimicrobial activity, the EEP has
antioxidant activity by the free radicals scavenging and the
ability to inhibit the lysis of erythrocytes incubated with
oxidizing agent, which was confirmed by lower generation of
MDA, one of biochemical markers of lipid peroxidation.
The antioxidant properties presented by T. fiebrigi propo-
lis extract are probably related to its chemical composition,
especially by the presence of phenolic compounds as benzoic
acid, cinnamic acid, and p-coumaric acid already described
in the literature by capacity to capture free radicals [36,
37]. Other studies have shown that these compounds are
responsible for the antioxidant activity by plant extracts [38–
40] and propolis [41, 42]. According to Valente et al. [43],
polyphenols frompropolis are able to capture peroxyl radicals
generated by AAPH oxidizing agent and inhibiting the lipid
peroxidation process resulting in protection against oxidation
of biomolecules present in the membrane of erythrocytes.
The reactive species of oxygen andnitrogen,when present
in high levels in the body, are responsible for oxidative stress
state, resulting in damage to cells and tissues [44]. Among
the possibilities to neutralize the excess of these free radicals
is consumption of natural foods with antioxidant properties,
which are important auxiliary in the prevention of diseases
related to oxidative stress, such as cancer, diabetes, and
diseases associated with inflammation, such as rheumatoid
arthritis and atherosclerosis [44, 45].
The propolis has also been used in the folk medicine in
the prevention of inflammatory diseases, despite the lack of
knowledge regarding the components that exhibit this activ-
ity. Inflammation is a biological response activated to restore
tissue injury, such as pathogens, damaged cells, irritants, and
free radicals. Propolis has been reported to possess anti-
inflammatory activity both in vitro and in vivo bymodulating
key inflammatory mediators, inhibiting the production of
proinflammatory cytokines, increasing anti-inflammatory
cytokines, and blocking the activation of nuclear factor-
(NF-) 𝜅B [46, 47]. Activity was also observed in the propo-
lis from T. fiebrigi by determination of the hyaluronidase
enzyme, an indirect way to assess the anti-inflammatory
activity. The hyaluronic acid is an important component of
articular cartilage and plays an important role in tissues’
renovation [22]. The degradation of hyaluronic acid by
hyaluronidase enzyme may cause bone loss, inflammation,
and pain [48].
The cytotoxic activity shown by EEP from T. fiebrigi
can be related to the presence of phenolic compounds as
coumaric acid, cinnamic acid, and derivatives. These com-
pounds have already been described in propolis samples by
their cytotoxic action against K562 (leukemia), HeLa (human
cervical adenocarcinoma), and LNCaP (human prostate can-
cer) cell lines [49–51].
By investigating the cytotoxic potential of propolis from
T. fiebrigi in K562 erythroleukemia cells, we observed the pre-
dominance of death by necrosis.This type of cell death can be
promoted by opening mitochondrial permeability transition
pores, leading to the depolarization and consequent cell death
due to lack of ATP [52]. For many years, necrosis was seen
as a kind of uncontrolled accidental death; however, necrosis
is currently described as a programmed death that may
contribute to the control of cancer-cell proliferation [53], in
particular in cell lines resistant to conventional chemotherapy
or cells showing resistance to apoptosis.
The K562 erythroleukemia cell line is described as
exhibiting resistance to death by apoptosis [54]; therefore,
alternative forms of cell death, such as necrosis, are neces-
sary to inhibit the proliferation of these tumor cells [55].
Necrosis is caused by several biochemical and molecular
signaling mechanisms, such as increases in levels of calcium
in cell cytoplasm, increased interactionwith serine-threonine
kinase receptors, and increased abundance of reactive oxygen
species, resulting in the disruption of organelles and cell death
[56].
5. Conclusions
These results show that propolis from the stingless bee T. fieb-
rigi has important biological activities, including antimicro-
bial, antioxidant, anti-inflammatory, and cytotoxic activity
against human erythroleukemia cell, suggesting its potential
application in the pharmaceutical industry, as well as in
health foods, beverages, and nutritional supplements.
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